Anjarium Biosciences
ID: 5316426Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.
3
Funding Rounds
$121.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo*** de Be** |
|
- | - |
Funding series
Funding Series Analysis
The company Anjarium Biosciences has raised a total of $121m in funding over 3 rounds.
Key Insights:
- Anjarium Biosciences Series A round, September 2021: $61m
- Anjarium Biosciences September 2021 Series A Funding Round: $60m
Industries
Anjarium Biosciences is active in the following industries: